Intec Pharma Banner Image

Intec Pharma

  • Ticker NTEC
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Intec Pharma Logo Image
  • 51-200 Employees
  • Based in Jerusalem, Israel
Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism. The Company'sMore product pipeline includes two product candidates in clinical trial stages: Accordion Pill Carbidopa/Levodopa, or AP-CD/LD, which is in late-stage Phase 3 development for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients, and AP-cannabinoids, an Accordion Pill to deliver either or both of the primary cannabinoids contained in Cannabis sativa, cannabidiol (CBD) and tetrahydrocannabinol (THC) for various pain indications. In addition, the Company has a feasibility agreement for the development of a custom-designed Accordion Pill for a proprietary compound with Novartis Pharmaceuticals.
4.8 / 5.0 (336)

Intec Pharma reports have an aggregate usefulness score of 4.8 based on 336 reviews.

Intec Pharma

Most Recent Annual Report

Intec Pharma
MOST RECENT 2020 Annual Report and Form 10K

Older/Archived Annual Reports

Intec Pharma Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!